Tibezonium iodide
From Wikipedia, the free encyclopedia
 |
|
|
Tibezonium iodide
|
|
| Systematic (IUPAC) name | |
| diethyl-methyl-[2-[ [2-(4-phenylsulfanylphenyl)-1H-1,5-benzodiazepin-4-yl]sulfanyl]ethyl]azanium iodide | |
| Identifiers | |
| CAS number | ? |
| ATC code | A01 |
| PubChem | |
| Chemical data | |
| Formula | C28H32IN3S2 |
| Mol. mass | 601.608 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tibezonium iodide (or tibenzonium iodide) is a stomatological preparation.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||
